ALHC Stock Drop Alert: BFA Law Announces Securities Fraud Investigation Into Alignment Healthcare Following Alleged Adjusted EBITDA Manipulation
ALHC Stock Drop Alert: BFA Law Announces Securities Fraud Investigation Into Alignment Healthcare Following Alleged Adjusted EBITDA Manipulation
BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost executive compensation.
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop.
If you invested in Alignment securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alignment-class-action-lawsuit.
Key Details of the Alignment ($ALHC) Class Action Investigation:
- Investigation Overview: Securities fraud relating to allegations that Alignment artificially inflated adjusted EBITDA to boost executive compensation.
- Stock Decline: July 8, 2026 – 16.7% Stock Drop
- Action: Contact BFA Law to discuss your rights
Why is Alignment Being Investigated for Securities Fraud?
Alignment is a healthcare services company that operates a platform focused on managing Medicare Advantage plans.
BFA is investigating allegations that Alignment artificially inflated adjusted EBITDA to boost executive compensation.
Why did Alignment’s Stock Drop?
On July 8, 2026, reports emerged that Alignment’s former chief technology officer filed a whistleblower lawsuit alleging that Alignment purposefully misclassified $8 million to $10 million in routine operating expenses as capital expenditures to artificially inflate adjusted EBITDA and boost executive compensation. According to the lawsuit, these misclassifications enabled Alignment to report its first positive adjusted EBITDA of $1.3 million in 2024 instead of a loss between $7 million and $9 million.
Following that announcement, Alignment shares fell approximately 16.7% on July 8, 2026.
Click here for more information: https://www.bfalaw.com/cases/alignment-class-action-lawsuit.
What Can You Do?
If you invested in Alignment securities, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
https://www.bfalaw.com/cases/alignment-class-action-lawsuit
Or contact:
Adam McCall
adam@bfalaw.com
212.789.3619
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “Super Lawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
https://www.bfalaw.com/cases/alignment-class-action-lawsuit
Attorney advertising. Past results do not guarantee future outcomes.
Adam McCall
adam@bfalaw.com
212.789.3619
View source version on businesswire.com: https://www.businesswire.com/news/home/20261020363696/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
6 ETFs To Diversify Away From AI
Why This Vanguard ETF Is One of the Best
The Best AI Stocks to Buy Now